Abstracts

Search by keyword or author name.

Showing 852 abstracts.

Howard Max Rosenblatt, M.D., Lin-Ye Song, Ph.D., Kenneth Stanley, Ph.D., Sharon Appelbaum Nachman, M.D., Paul Krogstad, M.D., George M. Johnson, M.D., Andrew A. Wiznia, M.D. Tetanus immunity and response to DTaP booster immunization in children with stable HIV on HAART. Presented at: 11th Conference on Retroviruses and Opportunistic Infections.

Conference

11th Conference on Retroviruses and Opportunistic Infections
Susan A. Fiscus, Ph.D., Ada Cachafeiro, Sonia Napravnik, M.P.H., Ph.D. The Cavidi Exavir viral load and phenotype assays in comparison to HIV-1 RNA and genotyping assays. Presented at: 15th Conference on Retroviruses & Opportunistic Infections.

Conference

15th Conference on Retroviruses & Opportunistic Infections
Kimberly Shankwitz, Lesley de Armas, Alexander Kizhner, Suresh Pallikkuth, Rajendra Pahwa, Grace Montepiedra, Mauricio Pinilla, Amita Gupta, Savita Pahwa, Jyoti Mathad. The Effect of HIV and Latent Tuberculosis Infection During Pregnancy on Infant Immune Development in IMPAACT P1078 study cohort. Presented at: International Workshop on HIV Pediatrics.

Conference

International Workshop on HIV Pediatrics

Study

P1078
Ross E. McKinney, Jr., M.D. The Efficacy of Oral, Intermittent Zidovudine (ZDV) in a Phase II Pediatric Trial (AIDS Clinical Trials Group Study 043).
Lawrence D'Angelo, M.D., M.P.H. The Enrollment of HIV Infected Adolescents in Clinical Trials: The Experience of ACTG Protocol 220.
The HIV prevalence of women entering labour with unknown HIV status who accepted or declined VCT. Presented at: South African Society of Obstetricians & Gynaecologists.

Conference

South African Society of Obstetricians & Gynaecologists

Study

P1031A
Bret J. Rudy, M.D., Jane C. Lindsey, Sc.D., Michael Hughes, Ph.D., Patricia M. Flynn, M.D., M.S. The impact of adherence in adolescents initiating HAART: data from the PACTG 381 cohort. Presented at: 12th Conference on Retroviruses and Opportunistic Infections.

Conference

12th Conference on Retroviruses and Opportunistic Infections
Susan Brogly, Ph.D., George D. McSherry, M.D., James M. Oleske, M.D., George Seage, III, Sc.D., M.P.H. The incidence and types of malignancy in perinatally infected HIV-positive children.
Robert C. Stevens, Pharm.D., Lisa M. Frenkel, M.D. The Influence of Dose and Food on Didanosine Systemic Exposure in HIV-Infected Children.
Richard M. Rutstein, M.D., Pearl Samson, M.S., Jennifer J. Kiser, Pharm.D., Courtney V. Fletcher, Pharm.D., Bobbie L. Graham, B.S., Steven M. Schnittman, M.D., Elizabeth (Betsy) Smith, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Terence Fenton, Ed.D., Grace M. Aldrovandi, MD. The PACTG 1020A protocol: atazanavir with or without ritonavir in HIV-infected infants, children, and adolescents. Presented at: 14th Conference on Retroviruses and Opportunistic Infections.

Conference

14th Conference on Retroviruses and Opportunistic Infections

Study

P1020A